Sign up to save your podcasts
Or
Share PTX is one step closer to finding a working cancer treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PTX is one step closer to finding a working cancer treatment
Prescient Therapeutics CEO Steven Yatomi-Clarke speaks with Finfeed about the latest results in the company's cancer treatment trials.
View all episodes
By FinfeedPrescient Therapeutics CEO Steven Yatomi-Clarke speaks with Finfeed about the latest results in the company's cancer treatment trials.